NEONC TECHNOLOGIES HOLDINGS, INC.

NTHI · Nasdaq · SIC 2834: Pharmaceutical Preparations
55
SEC Filings

Business Summary

Part I Overview Our company (f/k/a NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughou...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNTHIdiscussed_in_filing Artificial Intelligence
topic_mentionNTHIdiscussed_in_filing Quantum Computing
topic_mentionNTHIdiscussed_in_filing Cybersecurity
topic_mentionNTHIdiscussed_in_filing Trusted Computing
topic_mentionNTHIdiscussed_in_filing Blockchain & Crypto
topic_mentionNTHIdiscussed_in_filing Capital Expenditure
topic_mentionNTHIdiscussed_in_filing Regulation
topic_mentionNTHIdiscussed_in_filing Automotive
topic_mentionNTHIdiscussed_in_filing Healthcare & Bio
topic_mentionNTHIdiscussed_in_filing Platform & Ecosystem
topic_mentionNTHIdiscussed_in_filing Artificial Intelligence
topic_mentionNTHIdiscussed_in_filing Quantum Computing
topic_mentionNTHIdiscussed_in_filing Cybersecurity
topic_mentionNTHIdiscussed_in_filing Trusted Computing
topic_mentionNTHIdiscussed_in_filing Blockchain & Crypto
topic_mentionNTHIdiscussed_in_filing Capital Expenditure
topic_mentionNTHIdiscussed_in_filing Regulation
topic_mentionNTHIdiscussed_in_filing Automotive
topic_mentionNTHIdiscussed_in_filing Healthcare & Bio
topic_mentionNTHIdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001829126-26-002860EDGAR109K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001829126-25-009210EDGAR23K words
2025-08-182025-06-300001829126-25-006431EDGAR—
2025-05-092025-03-310001829126-25-003527EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001829126-26-003165EDGAR1K words
2026-03-230001829126-26-002610EDGAR—
2026-03-170001829126-26-002331EDGAR—
2026-03-060001829126-26-002020EDGAR—
2026-03-040001829126-26-001927EDGAR—
2026-03-030001829126-26-001885EDGAR—
2026-02-270001829126-26-001755EDGAR—
2026-01-290001829126-26-000757EDGAR—
2025-12-170001829126-25-010101EDGAR—
2025-12-050001829126-25-009754EDGAR—

55 total filings indexed. 41 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001979414
TickerNTHI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1f9c7e404f9bc2639240999fb4072484b4e3b9a634c8cd200499803c21b1533d
parent: 6704cd5d5d392ff92fc76f2a60c9d2a69f67b2f2fc0f61a0a17c7466fdc8f533
content hash: 77eb4151075823d7801c42bd1537a0fd0da21cfe72dcb4f6dc64ddf818d4090b
signed: 2026-04-13T04:46:36.061Z
sources: 4 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf